ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4902ometendo-4902Research ArticleСтатьиArticlesСовременные положения по использованию ЗГТ у женщин в менопаузе в рамках позиции Исполнительного комитета Международной Ассоциации по менопаузеSovremennye polozheniya po ispol'zovaniyu ZGT u zhenshchin v menopauze v ramkakh pozitsii Ispolnitel'nogo komiteta Mezhdunarodnoy Assotsiatsii po menopauzeGrigoryanO R-Mel'nichenkoG A-20041506200412№2 (2004)4547Copyright © Grigoryan O.R., Mel'nichenko G.A., 20042004Grigoryan O.R., Mel'nichenko G.A.Grigoryan O.R., Mel'nichenko G.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4902ReferencesAdams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary atherosclerosis by 17®-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 1990; 10; 1051-7Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary atherosclerosis by 17®-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis 1990; 10; 1051-7Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. J Am Med Assoc 2003; 289:3243-53Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. J Am Med Assoc 2003; 289:3243-53Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933-41Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933-41Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone treatment and mortality. N Engl J Med 1997; 336:1769-75Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone treatment and mortality. N Engl J Med 1997; 336:1769-75Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health- related quality of life. N Engl J Med 2003;348:1839-54Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health- related quality of life. N Engl J Med 2003;348:1839-54Herrington DM, Reboussin DR, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000; 343:522-9Herrington DM, Reboussin DR, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000; 343:522-9Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for sec- ondary prevention of coronary disease in postmenopausal women. J Am Med Assoc 1998; 280:605-13Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for sec- ondary prevention of coronary disease in postmenopausal women. J Am Med Assoc 1998; 280:605-13Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart dis- ease and changes in diet and lifestyle in women. N Engl J Med 2000; 343:530-7Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart dis- ease and changes in diet and lifestyle in women. N Engl J Med 2000; 343:530-7Joakimsen O, B_naa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis. J Clin Epidemiol 2000; 53:525-30Joakimsen O, B_naa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis. J Clin Epidemiol 2000; 53:525-30Karas RH, Clarkson TB. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med 2003; 10:8-12Karas RH, Clarkson TB. Considerations in interpreting the cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Med 2003; 10:8-12Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coro- nary heart disease. N Engl J Med 2003; 349:523-34Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coro- nary heart disease. N Engl J Med 2003; 349:523-34Mack WJ, Hameed AB, Xiang M, et al. Does elevated body mass modify the influ- ence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis 2003; 168:91-8Mack WJ, Hameed AB, Xiang M, et al. Does elevated body mass modify the influ- ence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis 2003; 168:91-8Million Women Study Collaborators. Breast cancer and hormone replacement ther- apy in the Million Women Study. Lancet 2003; 362:419-427Million Women Study Collaborators. Breast cancer and hormone replacement ther- apy in the Million Women Study. Lancet 2003; 362:419-427Naftolin F, Taylor HS, Karas R. Early initiation of hormone therapy and clinical car- dioprotection: the Women's Health Initiative (WHI) could not have detected cardio- protective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004: in pressNaftolin F, Taylor HS, Karas R. Early initiation of hormone therapy and clinical car- dioprotection: the Women's Health Initiative (WHI) could not have detected cardio- protective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004: in pressRossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288:321-33Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002; 288:321-33Shapiro S. Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: the validity of the epidemiological evidence. In Schneider HPG, Naftolin F, eds. Climacteric Medicine - Where Do We Go? Proceedings of the 4th Workshop of the International Menopause Society. London: Parthenon Publishing, 2004: in pressShapiro S. Effects of hormone replacement therapy on the risks of breast cancer and cardiovascular disease: the validity of the epidemiological evidence. In Schneider HPG, Naftolin F, eds. Climacteric Medicine - Where Do We Go? Proceedings of the 4th Workshop of the International Menopause Society. London: Parthenon Publishing, 2004: in press
The authors declare that there are no conflicts of interest present.